Accelus reaches a milestone with a new implant and three more updates from spine devicemakers since Aug. 10:
1. ZimVie on Aug. 10 reported net sales of $233.4 million in the second quarter. Read more details here.
2. Max Reinhardt was elected to the board of directors at Sure Retractors, a medical device company specializing in spinal surgery.
3. Kalman Blumberg, MD, was first to use Accelus' TiHawk11 interbody fusion system, and 150 devices have been implanted since.
4. Intraoperative neuromonitoring company Assure Holdings saw its second-quarter 2022 managed case volume jump by about 36 percent year over year. Read more here.